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Background: While depression is frequently managed by general practitioners, often patients self-manage these
symptoms with alternative therapies, including St John’s wort (SJW). We tested whether use of SJW was associated
with different patterns of conventional and complementary health service use, strategies used for management of
depression, or user dissatisfaction with or lack of trust in their general practitioner or clinic overall.
Methods: Secondary analysis of data collected from an Australian population screened for a longitudinal cohort
study of depression. Main outcome measures were CES-D for depressive symptoms, satisfaction with their general
practitioner (GPAQ), Trust in Physician scale, self-report of health services usage and strategies used to manage
depression, stress or worries.
Results: Response rate was 7667/17,780 (43.1%). Of these, 4.3% (320/7,432) had used SJW in the past 12 months
(recent ‘SJW users’). SJW users were significantly more likely to be depressed and to have a higher CES-D score.
There were no statistically significant differences between recent SJW users and non-SJW users in satisfaction with
their general practice or in trust in their general practitioner (GP) when adjusted for multiple factors. SJW users
were significantly more likely to use all health services, whether conventional or complementary, as well as other
strategies used for mental health care. SJW users were also more likely to consider themselves the main carer for
their depression.
Conclusions: Primary care attendees with symptoms of depression who use SJW appear not to be rejecting
conventional medicine. Rather, they may be proactive care seekers who try both conventional and complementary
strategies to manage their depressive symptoms. If GPs enquire and find that their depressed patients are using
SJW, this may indicate that they might explore for unrelieved symptoms of depression and also consider the issue
of potential for interactions between SJW and other medicines.
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Patient careBackground
Depression is a condition commonly managed in general
practice. Treatments available to people experiencing
depression and other mental health problems include
prescription medicines, over-the-counter treatments,
care from medical and other practitioners, as well as
self-initiated options [1]. Many people with mental
health issues do not seek formal care [2].* Correspondence: mpirotta@unimelb.edu.au
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unless otherwise stated.St John’s wort (SJW, botanical name Hypericum perfora-
tum) has been used for centuries in the treatment of
mental health disorders. SJW is a herbal medicine that
doctors need to be aware of due to its popularity, evi-
dence of its effectiveness in depression, and its potential
for interactions with other medicines. SJW forms part of
the standard care for depression in Germany [3] and has
been found to be one of the more popular complementary
and alternative medicines (CAM) used by consumers in
the US [4]. In an Australian community-based sample of
three age cohorts (N = 7485), over the past month 5.6%Ltd. This is an Open Access article distributed under the terms of the Creative
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a complementary or alternative medicine (CAM) for de-
pression and 2.4% for anxiety, of which, two-thirds
(63%) had taken SJW [5].
Of all CAM, SJW has been the most tested in clinical
trials [6]. A Cochrane review found evidence to support
the use of SJW for treatment of major depression [7].
Although SJW has fewer side effects than conventional
antidepressants, it has clinically important interactions
with some conventional drugs, in particular, with select-
ive serotonin reuptake inhibitors (SSRIs) [3]. It is for this
reason that the National Institute for Health and Care
Excellence (NICE) clinical guidelines do not recommend
its use in the United Kingdom.
Herbal medicines are regulated slightly differently in
different countries, which may have an impact on its
availability to consumers. SJW is regulated in the UK by
the Medicines Healthcare products Regulatory Agency
(MHRA). To sell a product containing SJW over-the-
counter in the UK, companies must obtain either full
Marketing Authorisation or Traditional Herbal Registra-
tion (THR). The former requires evidence of efficacy,
but companies can choose to follow the route of THR
which only requires evidence of traditional use, safety,
and quality of the product. In Australia, SJW is regulated
by the Therapeutic Goods Administration as a listed
medicine, in a similar process to THR. SJW may be rec-
ommended to patients by their general practitioners [8]
or by complementary therapists; however, SJW can also
be purchased over-the-counter with no professional in-
put, which is a concern due to its potential for interac-
tions with other medicines.
Little research has addressed why consumers use SJW
[2]. An interview-based study conducted in the United
States with 22 current users of SJW found four domin-
ant decision-making themes: (1) participants (or their
parents) had a history of CAM use and believed in per-
sonal control of their heath; (2) lowered mood; (3) self-
diagnosis of “minor” depression, high risks of prescription
drugs, and a perception of safety with herbal remedies,
and (4) barriers to and lack of knowledge of conventional
health care providers and awareness of the ease of use and
popularity of SJW [9].
No research has explored how people who use SJW for
depressive symptoms also use other treatments, whether
conventional or complementary or alternative. We explored
whether primary care attendees, who had used SJW to
manage depressive symptoms in the last 12 months, were
also more likely to use other strategies and components of
the conventional and complementary health care systems
to manage their depressive symptoms, and whether they
differed from non-SJW users in their satisfaction with or
trust in their general practitioner and their clinic overall.
Our hypothesis was that recent use of SJW would not beassociated with marked differences in health service use or
in attitudes to general practice compared with people who
had not used SJW.
Methods
We undertook a secondary cross sectional analysis of
screening data from a large cohort study in general prac-
tice, which explores how patients deal with depression,
stress or worries called the Diagnosis, Management and
Outcomes of Depression in Primary Care (diamond)
study conducted in Victoria, Australia. diamond is a
prospective, longitudinal cohort study of general practice
attendees with depression from 30 randomly selected
metropolitan and rural general practices, that began in
January 2005. Clinic records were searched to identify all
people aged 18-75 years who had seen the study GP in
the previous year. Each GP examined this list and ex-
cluded those people who could not read English, were
terminally ill, or resided in a nursing home. Between
January and December 2005, random samples of about
600 eligible people from each general practice were mailed
a screening survey with a covering letter from the GP and
one follow up reminder letter after two weeks.
In addition to this initial survey, we report some re-
sults from a baseline telephone interview, conducted on
average four weeks after the survey, between January
2005 and April 2006, with participants who met defined
diagnostic criteria for depression. The study received
Human Research Ethics Committee Approval from The
University of Melbourne and full details of the methods
have been reported [10].
Participant sample
Of the 17,780 people initially sent a screening survey as
part of the diamond study, 7,667 (43%) returned a com-
pleted survey. The mean age of people who were sent
the screening survey was 46.2 years (SD 15.3) and 60.7%
were women. People who returned the survey were on
average older (50.9 years; SD 14.2) and more likely to be
female (66.5%).
Of these respondents, 97% (N = 7,432) answered a
question on whether they had used St John’s wort for
depression, stress or worries during the past 12 months
and thus form our sample and the comparison groups
for this study (recent SJW users and non-SJW users).
The 12 month timeframe was chosen to allow a com-
parison with use of health care services, self-initiated strat-
egies used for depression, stress or worries, and other
scales which measure outcomes over the same timeframe.
Measures
In addition to the Centre for Epidemiologic Studies De-
pression Scale (CES-D) used to identify depressive
symptoms for both the screening and outcome measures
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following topics and used the following validated scales:
(i) Use of health care practitioners
Participants were asked whether in the past 12
months they had seen any traditional health
professionals (hospital doctor, specialist doctor,
physiotherapist, psychologist, counsellor,
psychiatrist, nurse, social worker, alcohol or drug
worker or family therapist) or complementary
therapists (chiropractor, naturopath, homeopath,
acupuncturist or other natural therapist).
(ii) Strategies tried for depression, stress or worries
Participants were also asked to indicate strategies
they had tried for depression, stress or worries in
the past 12 months by ticking items in a
comprehensive list. The list included the following
activities: exercise, yoga, counselling, hypnosis,
depression medication, sleeping medication,
acupuncture, relaxation or meditation, massage or
touch therapy, aromatherapy, changed diet, reduced
use of alcohol or illicit drugs, attended self-help
group for emotional wellbeing or alcohol or drug
withdrawal, read a self-help book, prayer, educa-
tional or therapeutic websites, telephone helpline
and talked to family or friends.
(iii) Satisfaction with general practice
The General Practice Assessment Questionnaire
(Version 1.0; GPAQ) measures satisfaction with
receptionists; access to practice; continuity of care;
communication; practice nurses; and practice
overall. The GPAQ has been validated in the UK, but
also has been tested in this Australian cohort [12].
(iv) Trust
The Trust in Physician scale [13] is an eleven-item in-
strument presented in a five-point Likert format. The
original scale was further validated and modified to
make it appropriate for the primary care setting: one
item, ‘My doctor is a real expert in taking care of med-
ical problems like mine’ was modified to read ‘My doc-
tor is well qualified to manage (diagnose and treat or
make an appropriate referral) medical problems like
mine’. The response labels were changed from (1 =
strongly disagree; 3 = uncertain; 5 = strongly agree) to
(1 = totally disagree; 3 = neutral; 5 = totally agree). The
last version of the instrument was used in the diamond
study. [14].
(v) Telephone interview
Finally, those participants who screened positive
for depressive symptoms (≥16 on the CES-D) and
entered the diamond cohort were asked at study
baseline in a computer assisted telephone inter-
view: ‘At present, who do you consider is the main
person caring for your depression?’Statistical analysis
Data were analysed using STATA version 11 [15] and
summarised using frequencies and percentages for cat-
egorical data, and means and standard deviations (SD)
for continuous data.
Participants were divided into two groups according to
whether or not they reported taking SJW in the past 12
months. Logistic regression was used to examine the
demographic characteristics of SJW users and to investi-
gate the association between SJW usage and 1) health
service use; 2) other strategies used for mental health
care; 3) depression scores measured by CES-D; and 4) in
the subgroup who screened positive for depression,
whether SJW users consider themselves the main carer
for their depression. Generalised estimating equations
with robust standard errors were used to allow for the
clustering effect, i.e. the correlation of individual re-
sponses from the same general practice.
Mixed effects linear regression models (treating the
GP practice as a random effect and patient characteris-
tics as fixed effects) were used to calculate differences in
means and 95% confidence intervals (CI) for GPAQ and
Trust in Physician scores. Satisfaction with nursing care
was reported only for participants from clinics with a
practice nurse.
A logistic regression model, used to analyse health ser-
vice use and other strategies, controlled for participant
characteristics including age, sex, general practice loca-
tion as well as general health rating and whether they
scored positively (≥16) for depressive symptoms on
CES-D. These participant characteristics were chosen
because of their association with patient ratings of GPs
[16]. In terms of general practice location, participants
were classified into Socio-Economic Indexes for Areas
(SEIFA) deciles on the Index of Relative Socio-economic
Disadvantage (IRSD) and Index of Relative Socio-economic
Advantage and Disadvantage (IRSAD). The IRSAD pro-
vides a continuum score (or decile) of advantage (high
values) to disadvantage (low values). The IRSD only
measures relative disadvantage, so a high score (or de-
cile) reflects a relative lack of disadvantage rather than
relative advantage. Cut-off points of 8 in IRSD and 9 in
IRSAD were created based on grouping contiguous
values of SEIFA deciles in the sample into two halves,
where the first half was associated with lower scores
and the second half with higher scores [17].
The mixed effects linear regression models investigat-
ing associations between satisfaction, trust and various
aspects of their general practice were additionally con-
trolled for number of visits to the participant’s usual GP,
and the number of GPs seen in the previous year.
The association between SJW use and caring for own
depression was undertaken with logistic regression using
generalised estimating equations with robust standard
Table 1 Participant characteristics
Non-SJW user SJW user OR (95% CI)† P value
Participant characteristics (N = 7112, N %)* (N = 320, N %)*
General practitioner location
Urban (RRMA 1&2) 4771 (67.1) 237 (74.1) Ref 0.20
Rural (RRMA 3-5) 2341 (32.9) 83 (25.9) 0.70 (0.41, 1.20)
SEIFA – IRSD (8+)‡ 3374 (47.4) 185 (57.8) 1.54 (0.99, 2.37) 0.05
SEIFA – IRSAD (9+)§ 3410 (47.9) 188 (58.8) 1.54 (1.00, 2.37) 0.05
Age group
18-34 1085 (15.4) 68 (21.5) Ref <0.001
35-54 2974 (42.2) 176 (55.5) 0.95 (0.65, 1.41)
55-76 2982 (42.4) 73 (23.0) 0.42 (0.27, 0.64)
Gender
Male 2419 (34.1) 48 (15.1) Ref <0.001
Female 4680 (65.9) 270 (84.9) 2.71 (2.08, 3.54)
Marital status
Never married/Single 1235 (17.5) 89 (28.3) Ref <0.001
Widowed/Divorced/Separated 1245 (17.7) 70 (22.2) 0.81 (0.58, 1.13)
Married 4559 (64.8) 156 (49.5) 0.52 (0.39, 0.69)
Born in Australia 5735 (80.8) 268 (84.3) 1.35 (0.97, 1.88) 0.07
English is first language 6710 (94.7) 308 (96.3) 1.44 (0.76, 2.71) 0.26
Lives alone 963 (13.6) 42 (13.2) 0.94 (0.67, 1.30) 0.70
Highest level of education
Completed year 12 or less 4038 (57.1) 133 (41.7) Ref 0.003
Certificate/Diploma 1456 (20.6) 86 (27.0) 1.64 (1.21, 2.22)
Bachelor degree or higher 1584 (22.4) 100 (31.3) 1.67 (1.22, 2.29)
Employment
Employed/Student 4504 (63.5) 229 (71.6) Ref 0.04
Not employed¶ 2209 (31.1) 74 (23.1) 0.70 (0.53, 0.92)
Unable to work 383 (5.4) 17 (5.3) 0.94 (0.54, 1.65)
Pension/benefit is main source of income 1841 (26.2) 71 (22.4) 0.88 (0.66, 1.17) 0.37
Ever told by doctor had depression 1981 (30.1) 193 (65.6) 4.22 (3.27, 5.45) <0.001
Ever told by doctor had anxiety 1492 (24.0) 157 (56.7) 3.91 (2.96, 5.17) <0.001
Currently taking depression medication 962 (13.7) 84 (26.3) 2.20 (1.73, 2.80) <0.001
Long term illness/Health problem/ disability 2243 (32.3) 108 (34.5) 1.13 (0.90, 1.44) 0.29
Health rate
Fair/Poor 1155 (16.4) 63 (19.9) Ref 0.09
Good/Excellent 5867 (83.6) 253 (80.1) 0.78 (0.59, 1.04)
GP female 1915 (26.9) 122 (38.1) 1.58 (1.12, 2.24) 0.009
Seen a GP 12 or more times in past 12 months 652 (9.2) 32 (10.0) 1.11 (0.75, 1.63) 0.60
OR = odds ratio. RRMA = Rural, Remote and Metropolitan Areas classification. SEIFA = Socio-Economic Indexes for Areas. IRSD = Index of Relative Socio-Economic
Disadvantage. IRSAD = Index of Relative Socio-Economic Advantage/Disadvantage. *Denominators may vary due to missing data. †Odds ratios, 95% confidence
intervals and P values with logistic regression using generalised estimating equations with robust standard errors. ‡Participants were classified into deciles on the
IRSD and IRSAD, based on their general practitioner’s geographic location. IRSD measures relative disadvantage so a high score implies a relative lack of disadvantage.
§IRSAD provides a continuum score (or decile) of advantage (high values) to disadvantage (low values). ¶Includes home duties, unpaid work and maternity leave.
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general practice location and additionally for depression
measured by Patient Health Questionnaire (PHQ) [18].
Results are reported as unadjusted and adjusted odds ra-
tios (ORs) with 95% confidence intervals [CI] and p values
(p). Due to the number of analyses conducted, statistical
significance was set at p < 0.01.
Results and discussion
Of 7667 participants, 1793 (23.4%) screened positive for a
probable diagnosis of depression on the CES-D (> = 16). Of
participants responding to the diamond screening survey
question on SJW use, a total of 4.3% (320/7432; 95% CI
3.8%, 4.8%) reported using SJW in the past 12 months,
compared with 18.2% (1351/7432, 95% CI 17.3%, 19.1%)
who used antidepressants. The demographic characteristics
of participants are shown in Table 1. SJW users were more
likely to be younger, female, single, have completed higher
education, employed, to have been told by their doctor that
they have depression or anxiety, taking medications for de-
pression and to see a female GP.
SJW use was associated with a diagnosis of probable
depression as rated by CES-D score of 16 or more (CES-
D > =16: 43.8% SJW users; 23.5% non-SJW users; OR 2.44,
95% CI 1.99, 3.00, p < 0.001). We separated participants
according to two recommended cut-off scores ≥16 (indi-
cating probable depression) and ≥ 20 (indicating a signifi-
cant elevation in depressive symptomatology in primary
care sample). [19,20] See Table 2.
We explored how this sample used both conventional
and complementary health practitioners. After adjust-
ment for self-rated health status, SJW users were signifi-
cantly more likely to see their GP five or more times in
the past year (51.3%, 43.3%), although this became non-
significant when further adjusted for depression score.
SJW users were significantly more likely to use all other
health services, whether conventional or complementary
(see Table 3).
When examining self-initiated strategies used for de-
pression, stress or worries, SJW users were significantly
more likely to have tried all listed strategies (see Table 4).
For example, SJW users were more likely to have tried
counsellors [adjusted Odds Ratio (adj OR) 3.45, 95% CI
2.38, 5.01] and sleeping tablets (adj OR 2.46, 95% 1.73,
3.52), but also acupuncture (adj OR 6.00, 95% CI 3.71,Table 2 Depression scores of diamond participants by CES-D
Non-SJW user SJ
(N = 7112, N %) (N
Not depressed (<16) 5349 (76.5) 18
16-19 473 (6.8) 36
20-60 1166 (16.7) 10
CES-D = Center for Epidemiological Studies Depression Scale. OR = odds ratio. *Den
intervals and P values with logistic regression using generalised estimating equatio9.69), hypnosis (adj OR 5.31, 95% CI 2.90, 9.74) or
aromatherapy (adj OR 4.30, 95% CI 3.26, 5.67).
Table 5 shows no statistically significant differences in
participants’ satisfaction with various aspects of their gen-
eral practice or in their trust in their GP when adjusted for
age, gender, general practice location, health rating, number
of general practice visits, number of general practitioners
seen and for depression score.
Finally, those participants who fulfilled diagnostic cri-
teria for depression on the CES-D scale were asked in a
computer assisted telephone interview (CATI) (n = 717;
from those there were 5 missing responses related to
usage of SJW) who they considered was the main person
caring for their depression (if the participant did not iden-
tify with the term ‘depression’, the interviewer then used
the phrase ‘or the way you are feeling’). The association
between SJW use and caring for own depression was in-
vestigated using logistic regression controlled for the ef-
fects of age, sex, general practice location and additionally
for depression measured by Patient Health Questionnaire
(PHQ) [18]. Half (50%; n = 32) of SJW users considered
that they themselves were the main person caring for their
depression, compared to 33.8% (n = 219) of non-SJW
users. SJW users were more likely to consider themselves
as the main person caring for their depression, and this
association was significant (OR = 1.97; 95% CI 1.02, 3.83;
p < 0.05). In contrast, only 9% of SJW users thought that a
GP was the main person caring for their depression, com-
pared to 16% of non-SJW users.
Conclusions
Summary of main findings
Our research has three main findings. Importantly in
this large randomly selected general practice population,
we found that recent SJW users were no different from
non-SJW users in their satisfaction with various aspects
of their general practice experience or in their trust in
their GP. However, SJW users were significantly more
likely to use all health services in general and to use a
wide range of strategies for their depression, both con-
ventional and complementary. Of participants currently
depressed, SJW users were more likely to consider them-
selves the main carer for their depression, while non-SJW
users were more likely to consider their GP to be the main
person caring for their depression. These findings mayscore
W-user OR (95% CI)† P value
= 320, N %)
0 (56.3) Ref <0.001
(11.3) 2.20 (1.60, 3.03)
4 (32.5) 2.54 (2.03, 3.17)
ominators may vary due to missing data. †Odds ratios, 95% confidence
ns with robust standard errors.
Table 3 Health Service Use of diamond study participants
Non-SJW user SJW-user Unadjusted† P Adjusteda† P Adjustedb† P Adjustedc† P
(N = 7112, N %)* (N = 320, N%) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)





























OR = odds ratio. GP = General Practitioner. *Denominators may vary due to missing data. †Odds ratios, 95% confidence intervals and P values with logistic
regression using generalised estimating equations with robust standard errors.
†Traditional includes: hospital doctor; specialist doctor; physiotherapist; psychologist; counsellor; psychiatrist; nurse; social worker; alcohol and drug worker; family
therapist. ‡Alternative includes: chiropractor; naturopath; homeopath; acupuncturist; other natural therapist.
aAdjusted for age, gender and general practice location.
bAdjusted for age, gender, general practice location and health rate.
cAdjusted for age, gender, general practice location, health rate and depression score.
Table 4 Strategies used for depression, stress or worries
Non-SJW user SJW-user Unadjusted† Adjusteda† Adjustedb† Adjustedc†
(N = 7112, N%)* (N = 320, N%)* OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Exercise 3207 (45.1) 256 (80.0) 3.99 (3.22, 4.95) 3.54 (2.90, 4.32) 3.51 (2.88, 4.27) 3.26 (2.63, 4.03)
Yoga 670 (9.4) 106 (33.1) 3.98 (3.09, 5.12) 3.24 (2.56, 4.09) 3.21 (2.52, 4.11) 3.03 (2.34, 3.92)
Counselling 896 (12.6) 138 (43.1) 4.75 (3.47, 6.49) 4.07 (2.93, 5.66) 3.92 (2.81, 5.48) 3.45 (2.38, 5.01)
Hypnosis 88 (1.2) 25 (7.8) 6.57 (3.53, 12.21) 5.87 (3.15, 10.93) 5.87 (3.19, 10.81) 5.31 (2.90, 9.74)
Depression medication 1222 (17.2) 129 (40.3) 3.21 (2.41, 4.26) 2.96 (2.24, 3.90) 2.81 (2.10, 3.78) 2.40 (1.71, 3.35)
Sleeping medication 828 (11.6) 96 (30.0) 3.07 (2.18, 4.32) 3.04 (2.17, 4.27) 2.89 (2.07, 4.03) 2.46 (1.73, 3.52)
Acupuncture 134 (1.9) 42 (13.1) 7.20 (4.44, 11.66) 6.62 (4.09, 10.70) 6.20 (3.86, 9.95) 6.00 (3.71, 9.69)
Relaxation/Meditation 1026 (14.4) 154 (48.1) 4.76 (3.91, 5.80) 4.09 (3.41, 4.90) 3.95 (3.27, 4.76) 3.70 (3.04, 4.50)
Massage/Touch therapy 999 (14.0) 136 (42.5) 4.05 (3.18, 5.15) 3.30 (2.66, 4.10) 3.25 (2.59, 4.08) 3.12 (2.48, 3.91)
Aromatherapy 411 (5.8) 91 (28.4) 6.16 (4.61, 8.22) 4.70 (3.59, 6.15) 4.62 (3.51, 6.09) 4.30 (3.26, 5.67)
Changed diet 1235 (17.4) 137 (42.8) 3.34 (2.70, 4.13) 2.90 (2.33, 3.62) 2.82 (2.27, 3.50) 2.59 (2.04, 3.28)
Reduced alcohol or drug 671 (9.4) 94 (29.4) 3.72 (3.02, 4.59) 3.57 (2.88, 4.42) 3.30 (2.61, 4.16) 2.95 (2.32, 3.76)
Attended self-help group
For emotional wellbeing 158 (2.2) 31 (9.7) 4.44 (2.81, 7.00) 4.02 (2.57, 6.29) 3.49 (2.18, 5.60) 3.10 (1.94, 4.93)
For alcohol or drugs 34 (0.5) 8 (2.5) 5.45 (2.30, 12.93) 5.36 (2.18, 13.19) 4.53 (1.74, 11.76)d 3.96 (1.38, 11.32)e
Read a self-help book 921 (13.0) 163 (50.9) 6.21 (4.79, 8.07) 5.34 (4.15, 6.87) 5.17 (3.97, 6.72) 4.69 (3.54, 6.21)
Prayer 1181 (16.6) 112 (35.0) 2.72 (2.22, 3.33) 2.49 (2.02, 3.07) 2.41 (1.95, 2.99) 2.21 (1.78, 2.75)
Educational/Therapeutic websites 173 (2.4) 40 (12.5) 5.27 (3.41, 8.15) 4.41 (2.91, 6.68) 4.26 (2.78, 6.54) 3.63 (2.38, 5.54)
Telephone helpline 123 (1.7) 24 (7.5) 4.51 (2.79, 7.31) 3.55 (2.11, 5.99) 3.15 (1.81, 5.51) 2.45 (1.36, 4.42)d
Talked to family or friends 2724 (38.3) 218 (68.1) 3.06 (2.37, 3.97) 2.49 (1.86, 3.33) 2.40 (1.79, 3.23) 2.15 (1.56, 2.96)
OR = odds ratio. *Denominators may vary due to missing data. †Odds ratios, 95% confidence intervals and P values with logistic regression using generalised
estimating equations with robust standard errors.
aAdjusted for age, gender and general practice location.
bAdjusted for age, gender, general practice location and health rate.
cAdjusted for age, gender, general practice location, health rate and depression score.
All p values <0.001, except where indicated otherwise; d p-value < 0.01 e p-value < 0.1.
Pirotta et al. BMC Complementary and Alternative Medicine 2014, 14:204 Page 6 of 10
http://www.biomedcentral.com/1472-6882/14/204
Table 5 GPAQ and Trust in Physician scores
Non-SJW user SJW-user
GPAQ item‡ (N = 6630) (N = 277) Unadjusted† P Adjusteda† P Adjustedb† P Adjustedc† P Adjustedd† P
Mean (SD) Mean (SD) COEF (95% CI) COEF (95% CI) COEF (95% CI) COEF (95% CI) COEF (95% CI)
Satisfaction with:
Receptionists 82 (19.0) 81 (21.0) 0.26 (-1.95, 2.46) 0.82 0.36 (-1.85, 2.58) 0.75 0.38 (-1.85, 2.62) 0.74 0.12 (-2.10, 2.34) 0.92 0.35 (-1.88, 2.58) 0.76
Access to practice 68.63 (16.8) 64.8 (15.9) −1.99 (-3.84, -0.14) 0.04 −1.65 (-3.51, 0.20) 0.08 −1.55 (-3.41, 0.32) 0.10 −1.74 (-3.59, 0.12) 0.07 −1.38 (-3.24, 0.48) 0.15
Continuity of care 77 (20.0) 75 (22.0) −0.42 (-2.78, 1.94) 0.73 0.01 (-2.36, 2.37) 0.10 0.43 (-1.95, 2.82) 0.72 −0.003 (-2.34, 2.34) 0.10 0.22 (-2.12, 2.57) 0.85
Communication 83.96 (16.0) 85.07 (15.8) 0.44 (-1.41, 2.30) 0.64 0.04 (-1.82, 1.91) 0.97 0.17 (-1.71, 2.04) 0.86 −0.08 (-1.95, 1.78) 0.93 0.28 (-1.59, 2.14) 0.77
Nursing care§ 80.03 (16.4) 77.95 (20.1) −1.36 (-4.81, 2.08) 0.44 −1.41 (-4.87, 2.04) 0.42 −1.30 (-4.80, 2.19) 0.47 −1.27 (-4.75, 2.22) 0.48 −0.94 (-4.43, 2.55) 0.60
Practice overall 81.59 (20.4) 79.59 (19.4) −1.45 (-3.90, 1.00) 0.25 −1.51 (-3.98, 0.96) 0.23 −1.31 (-3.78, 1.17) 0.30 −1.49 (-3.96, 0.98) 0.24 −1.10 (-3.58, 1.37) 0.38
Trust in physician:
Score transformed¥ 77.09 (13.7) 75.35 (14.7) −1.65 (-3.29, -0.002) 0.05 −1.64 (-3.30, 0.01) 0.05 −1.46 (-3.12, 0.21) 0.09 −1.69 (-3.34, -0.04) 0.04 −1.22 (-2.87, 0.43) 0.15
COEF = coefficient. GPAQ = General Practice Assessment Questionnaire. *Denominators may vary due to missing data. †COEF, 95% confidence intervals and P values calculated using mixed effects linear regression
models (treating GP practice as a random effect and patient characteristics as fixed effects). ‡Scores are expressed as a percentage of the maximum possible score (100) for each GPAQ item, with higher scores
indicating greater satisfaction. §The eight general practices that did not have a practice nurse were excluded from the analysis for this item: the denominator is n = 5071 (4874/197). ¥Trust score transformed and
weighted for missing responses.
aAdjusted for age, gender and general practice location.
bAdjusted for age, gender, general practice location and health rate.
cAdjusted for age, gender, general practice location, health rate, no. of GP visits and no. of GPs seen.
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and who have experienced symptoms of depression do
not use SJW due to dissatisfaction with or lack of trust in
their general practitioner or their clinic; rather, it may be
that some aspects of their depression symptoms persist
and may be more severe or less responsive to convention
therapies and these participants sought additional help.
We did not ask participants who it was that recommended
that they try SJW, so it is possible that it was a recommen-
dation of their GP. Regardless, patients who had recently
used SJW are possibly a group more proactive in seeking
care.
Comparison with existing literature
In the diamond screening survey, nearly 25% of respon-
dents met the CES-D criteria for probable depression
and 18% had taken antidepressant medication in the past
year. Although this is considerably higher than figures
obtained by the population-based figures cited by the
Australian Bureau of Statistics, who found that 9.7% of
the population reported having an affective disorder
[21], it is in keeping with other surveys conducted in the
general practice setting [22].
Use of CAM in people with depression is common in
the community. A national Finnish study found that 43%
of people with ‘pure’ depression had used some type of
CAM in the past 12 months, nearly always as a ‘comple-
ment’ to mainstream care [23]. We found that the use of
one particular CAM, SJW, appears to be a marker of ac-
tive searching for relief in people experiencing depression,
not as a marker of a philosophical orientation to CAM. It
is not possible from our research to explore why this is so,
but this finding is supported by previous research about
complementary therapies in depression [23] and generally;
for example, a recent Dutch study found that many people
sought complementary therapists to obtain advice from a
different viewpoint, while less than 20% had concerns
about their mainstream care [24].
SJW users in general practice may prefer to seek care for
their depressive symptoms from a range of sources or they
may prefer to take responsibility for their care – the patient
as a consumer [25]. Some people prefer to avoid contact
with a GP altogether [26]. Alternatively, they may seek a
range of strategies as they are not obtaining the relief they
need from treatment being provided by their GP, which
may relate to many factors, such as concern about harm as-
sociated with pharmaceutical antidepressants, lack of re-
sponse to antidepressants or more severe depression [27].
Qualitative research is needed to explore these possibilities.
The meaning of the question ‘who do you consider the
main person caring for your depression’ is open to inter-
pretation: it could refer to provision of therapies, to day-
to-day care or to taking responsibility for choosing what
kinds of therapies to use. Each of these interpretationsinvites a different type of response. However, it does
seem that SJW users assume more personal responsibil-
ity for their depression care than non-SJW users.
Strengths and limitations of the study
The strengths of this research include the use of a large
randomly selected general practice-based sampling frame,
use of validated measures of depression, satisfaction and
trust, and exploration of the use of a wide range self-
initiated strategies for depression, stress or worries by gen-
eral practice attendees.
The limitations include a relatively low response rate
and that the survey was undertaken in only one Austra-
lian state, both of which could limit generalisability, reli-
ance on self-report and the potential for recall bias,
given that participants were requested to recall informa-
tion over the past 12 months. It is unlikely that recall
bias would affect differentially recall about the various
therapies used and therefore it should not have a major
impact on the results. It is not possible to determine
from this research whether use of SJW or other comple-
mentary therapies was recommended by a GP or not.
The data were collected in 2005/2006; however, while
this may be viewed as a limitation, popularity of comple-
mentary medicines has not diminished over this time
[28], so the findings of this research remain relevant.
Implications for future research or clinical practice
SJW use may be a marker of people searching for relief
from depression and who are willing to try multiple self-
help and professional treatments to deal with their prob-
lems. These people were also more likely to be users of
other medicines in the past year such as antidepressants
and sleeping tablets. While we cannot ascertain whether
this indicates concurrent use, it certainly raises the issue
of possible interactions with SJW. Authorities respon-
sible for medicines regulation and education need to be
aware of such use and put into place mechanisms to en-
sure that SJW users have access to information that ad-
dresses the potential risks of concurrent use.
In clinical practice, GPs should enquire about all CAM
use in their patients, including SJW use, as CAM products
may cause interactions or side-effects. Additionally in pa-
tients using SJW, GPs may need to enquire further about
unrelieved symptoms of depression and other strategies
their patients have tried; better communication about
these issues may improve the doctor-patient relationship,
and ultimately improve safe management of depression.
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